News

CSX Corporation Reports Impressive Year-End Financial Performance

CSX Corporation Reports Impressive Year-End Financial Performance

Overview of CSX Corporation's Financial Results

CSX Corp. (NASDAQ: CSX) has shown resilience in its recent financial disclosures. Announcing its fourth quarter and full year results for 2024, the company recorded an operating income of $1.11 billion for the final quarter. This figure indicates a decrease compared to the $1.32 billion reported in the same quarter of the previous year.

Despite a challenging economic environment, CSX managed to maintain a net income of $733 million, translating to $0.38 per diluted share. This reflects a decline from the $882 million, or $0.45 per diluted share, achieved in the corresponding period last year. Notably, the results for the fourth quarter included a significant pre-tax, non-cash goodwill impairment charge amounting to $108 million, influencing these outcomes.

Performance Insights for Full Year 2024

From a broader perspective, CSX's full-year performance for 2024 illustrates a 5% decrease in operating income, totaling $5.25 billion compared to the previous year. The net income for the entire year settled at $3.47 billion, or $1.79 per share, reflecting a slight dip from the year prior when net income reached $3.67 billion, or $1.82 per share.

When adjusted for the goodwill impairment charge, CSX's operating income for the fourth quarter stood at $1.21 billion, while for the full year, it was reported at $5.35 billion. The adjusted net income was reported at $815 million or $0.42 per diluted share for the quarter, and for the full year, it reached $3.55 billion or $1.83 per diluted share.

Strategic Initiatives and Future Focus

Joe Hinrichs, the President and CEO of CSX, expressed pride in the performance of the ONE CSX team. He acknowledged the challenges faced in 2024, including the impact of major hurricanes and operational hurdles like the Key Bridge outage. Nevertheless, he emphasized the company's commitment to delivering exceptional customer service. The focus for the upcoming year will be on maintaining safety, service excellence, and enhancing operational efficiency as they strengthen their network capabilities.

Fourth Quarter Financial Highlights

In reviewing the fourth quarter results, several financial highlights are notable:

  • Fourth quarter revenue came in at $3.54 billion, which marks a 4% decrease year-over-year. This drop primarily resulted from reduced fuel surcharge and coal revenue, notwithstanding stronger merchandise pricing and volume growth in intermodal services.
  • The operating income of $1.11 billion includes the $108 million goodwill impairment charge, with an adjusted operating income reaching $1.21 billion. The operating margin noted was 31.3%, improving to 34.3% when adjusted.
  • For earnings per share, CSX reported $0.38 with an adjusted EPS of $0.42, down from $0.45 in the previous year's quarter.

Full Year Financial Highlights

The full year financial highlights encompass:

  • Total revenue for 2024 reached $14.54 billion, a minor decrease of 1% from the previous year.
  • Operating income was reported at $5.25 billion, including the goodwill impairment, with adjusted operating income at $5.35 billion. For the year, the operating margin was noted at 36.1%, adjusting to 36.8%.
  • CSX achieved $1.79 in EPS, with adjusted EPS slightly higher at $1.83 compared to $1.82 from the prior year.

Engagement with Investors

CSX Corporation is committed to transparency and stakeholder engagement. The company regularly holds conference calls to discuss its financial performance and respond to investor inquiries. Recently, CSX executives hosted a conference call involving investors and the media to delve deeper into their financial updates. Interested parties were encouraged to participate and access the insights shared during this session.

For accessibility, presentation materials and a subsequent replay of the earnings call are available on CSX’s corporate investor relations website.

About CSX Corporation

As one of the premier transportation firms in the United States, CSX Corporation offers a wide array of rail services and solutions. With a rich history spanning nearly two centuries, CSX plays an essential role in the nation’s economic growth and infrastructure development. The company’s extensive network connects key metropolitan areas in the eastern United States, serving diverse markets including energy, industrial, construction, agricultural, and consumer products.

CSX’s commitment to innovation, safety, and efficiency positions it well for future growth while continuing to support the vital logistics and transportation needs of its customers.

Frequently Asked Questions

What were CSX's fourth quarter earnings for 2024?

CSX reported fourth quarter earnings of $733 million, equating to $0.38 per diluted share.

How did CSX manage revenue in 2024?

In 2024, CSX achieved total revenues of $14.54 billion, representing a 1% decline from the previous year.

What impact did the goodwill impairment charge have?

The goodwill impairment charge of $108 million significantly influenced the operating income reported for both the fourth quarter and the full year.

Who leads CSX Corporation?

Joe Hinrichs serves as the President and Chief Executive Officer of CSX Corporation.

What is CSX's commitment to customer service?

CSX remains dedicated to delivering industry-leading customer satisfaction through a focus on safety and operational efficiency.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 5

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 1

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 1

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 4

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 8

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 9

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading

Top 5 Most Recently Viewed Articles

Combining Forces: Waters Corporation and BD to Lead Diagnostics

Updated Category News Views 331

Exciting Merger in the Life Sciences Sector In a significant move for the life sciences industry, Waters Corporation (NYSE: WAT) has officially announced its plans to merge with BD (Becton, Dickinson and Company) (NYSE: BDX). This merger aims to create a leading entity in the fields of regulated and high-volume testing. The combination is expected to harness the strengths...

Continue Reading
Citius Oncology Strengthens LYMPHIR Launch with New Partnership

Updated Category News Views 109

Citius Oncology Reinforces Distribution for LYMPHIR Citius Oncology, Inc. (Nasdaq: CTOR), a leading company in oncology therapeutics, has taken a significant step by partnering with Cencora, a global provider of pharmaceutical solutions. The newly signed distribution services agreement is aimed at enhancing commercial infrastructure and ensuring the successful launch of...

Continue Reading
Exploring Growth in Low-Code Development Platforms

Updated Category News Views 242

Surging Growth in Low-Code Development Platforms The demand for low-code development platforms is on the rise, with projected growth from USD 26.30 billion in 2025 up to USD 67.12 billion by 2030, at an impressive CAGR of 20.61%. This surge is primarily fueled by organizations adopting hybrid and multi-cloud strategies, making low-code tools essential for modernizing...

Continue Reading
Foresee Pharmaceuticals Unveils Promising Results for Linvemastat

Updated Category News Views 58

Foresee Pharmaceuticals Announces Groundbreaking Phase 1 Results Foresee Pharmaceuticals (TPEx: 6576) is excited to share notable updates regarding its Phase 1 clinical trial of linvemastat (FP-020), a distinctive and selective oral MMP-12 inhibitor. The trial, focused on assessing safety, tolerability, and pharmacokinetics, has been successfully completed and has...

Continue Reading
Unlocking Spring’s Real Estate Potential with Mistoria Group

Updated Category News Views 302

Why May is the Optimal Time for Real Estate Transactions As the weather warms and spring settles in, the real estate market bursts with activity. Leading property experts suggest that May is the prime month to either buy or sell a home. Mish Liyanage, the CEO of Mistoria Group, emphasizes that emerging market trends provide compelling reasons for homeowners and potential...

Continue Reading